A major breakthrough for diabetes care has arrived in India. Novo Nordisk has launched Awiqli, the world's first once-weekly ...
Novo Nordisk India has launched the world's first once-weekly basal insulin, Awiqli, for adults with type 1 and type 2 diabetes. It reduces the injection burden from seven injections a week to just ...
Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side effects, and dosage. People with diabetes require insulin injections as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results